Arrowstreet Capital Limited Partnership lifted its position in shares of Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) by 35.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 322,090 shares of the company's stock after buying an additional 84,599 shares during the quarter. Arrowstreet Capital Limited Partnership owned approximately 0.80% of Phibro Animal Health worth $6,764,000 at the end of the most recent quarter.
A number of other institutional investors have also modified their holdings of the company. Geode Capital Management LLC grew its stake in Phibro Animal Health by 5.7% in the 3rd quarter. Geode Capital Management LLC now owns 507,469 shares of the company's stock worth $11,430,000 after acquiring an additional 27,201 shares during the period. Barclays PLC boosted its holdings in shares of Phibro Animal Health by 25.7% during the third quarter. Barclays PLC now owns 143,337 shares of the company's stock worth $3,228,000 after purchasing an additional 29,271 shares during the last quarter. FMR LLC grew its position in shares of Phibro Animal Health by 22.7% in the third quarter. FMR LLC now owns 39,310 shares of the company's stock valued at $885,000 after purchasing an additional 7,270 shares during the period. BNP Paribas Financial Markets increased its stake in Phibro Animal Health by 3.1% in the third quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company's stock valued at $548,000 after purchasing an additional 729 shares during the last quarter. Finally, Smith Group Asset Management LLC purchased a new position in Phibro Animal Health during the fourth quarter worth about $541,000. Institutional investors and hedge funds own 99.34% of the company's stock.
Phibro Animal Health Trading Down 1.2 %
Shares of NASDAQ:PAHC traded down $0.22 during trading on Friday, reaching $17.50. 251,349 shares of the stock were exchanged, compared to its average volume of 189,311. Phibro Animal Health Co. has a 12-month low of $12.30 and a 12-month high of $26.55. The firm's 50-day moving average price is $22.20 and its 200 day moving average price is $22.46. The company has a debt-to-equity ratio of 2.99, a quick ratio of 1.37 and a current ratio of 3.20. The firm has a market cap of $708.80 million, a price-to-earnings ratio of 36.46, a price-to-earnings-growth ratio of 0.45 and a beta of 0.63.
Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last released its quarterly earnings data on Wednesday, February 5th. The company reported $0.54 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. On average, sell-side analysts anticipate that Phibro Animal Health Co. will post 1.95 earnings per share for the current fiscal year.
Phibro Animal Health Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th were given a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 2.74%. The ex-dividend date was Wednesday, March 5th. Phibro Animal Health's dividend payout ratio (DPR) is presently 100.00%.
Wall Street Analyst Weigh In
PAHC has been the subject of several recent analyst reports. StockNews.com cut Phibro Animal Health from a "buy" rating to a "hold" rating in a report on Tuesday, March 25th. Barclays boosted their target price on shares of Phibro Animal Health from $20.00 to $22.00 and gave the company an "underweight" rating in a report on Monday, February 10th. Finally, Morgan Stanley increased their price target on shares of Phibro Animal Health from $20.00 to $25.00 and gave the stock an "equal weight" rating in a research note on Tuesday, December 17th. Two research analysts have rated the stock with a sell rating and three have issued a hold rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $21.00.
Read Our Latest Stock Report on PAHC
Phibro Animal Health Company Profile
(
Free Report)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Further Reading
Before you consider Phibro Animal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.
While Phibro Animal Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
